Anti-neutrophil cytoplasmic antibodies in patients with rheumatoid arthritis: Clinical, biological, and radiological correlations

Joint Bone Spine

Volumn 71, Issue 3, 2004, Pages 198-202

  Tur, Birkan Sonel ^a,b   Süldür, Nurben ^a   Ataman, Şebnem ^a   Tutkak, Hüseyin ^a   Atay, Mesut Birol ^a   Düzgün, Nurşen ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Cetin Emec Bulvari   (Turkey)

Author keywords

Anti neutrophil cytoplasmic antibodies; Disease activity; Myeloperoxidase; Proteinase 3; Radiography; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RADIOLOGY; RHEUMATOID ARTHRITIS; VASCULITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; PEROXIDASE;

EID: 2942522629     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2003.04.002     Document Type: Article

References (28)

1. Baum J., Ziff M. Laboratory findings in rheumatoid arthritis. 11th ed McCarty D.J. Arthritis and allied conditions. 1989;744-761 Lea and Febiger, Philadelphia
2. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R.J., et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 111:1999;507-513
3. Cohen Tervaert J.W., Kallenberg C.G. The role of autoimmunity to myeloid lysosomal ensymes in the pathogenesis of vasculitis. Hansson G., Libby P. Immune functions of the vessel wall. 1996;99-120 Harwood Academic Publishers, Amsterdam
4. Van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophil and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1:1985;425-429
5. Falk R.J., Jenette J.C. Anti-neutrophil cytoplasmic antibodies with specifity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and cresentic glomerulonephritis. N Engl J Med. 318:1988;1651-1657
6. Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 86:1990;202-210
7. Gross W.L., Schmitt W.H., Csernok E. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis. 18:1991;175-179
8. Csernok E., Gross W.L. Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects. Z Rheumatol. 54:1995;26-38
9. Mulder A.H., Horst G., van Leeween M.A., Limburg P.C., Kallenberg C.G.M. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations. Arthritis Rheum. 36:1993;1054-1060
10. de Bandt M., Meyer O., Haim T., Kahn M.F. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients. Br J Rheumatol. 35:1996;38-43
11. Mustila A., Paimela L., Leirisalo-Repo M., Huhtala H., Miettinen A. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis. An early marker of progressive erosive disease. Arthritis Rheum. 43:2000;1371-1377
12. Coreman I.E.M., Hagen E.C., Daha M.R., van der Woude F.J., van der Voort E.A., Kleijburg-van der Keur C., et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 35:1992;1466-1475
13. Röther E., Schochat T., Peter H.H. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: prospective study. Rheumatol Int. 15:1996;231-237
14. Braun M.G., Csernok E., Schmitt W.H., Gross W.L. Incidence, target antigens and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol. 23:1996;826-830
15. Vittecoq O., Jounen-Beades F., Krzanowska K., Bichon-Tauvel I., Menard J.F., Daragon A., et al. Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatol (Oxford). 39:2000;481-489
16. Savige J.A., Gallcchio M.C., Stockman A., Cunningham T.J., Rowley M.J., Georgiou T., et al. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Clin Exp Immunol. 86:1991;92-98
17. Arnett F.C., Edworthy S.M., Bloch D.A., McShare D.J., Fries J.F., Cooper N.S., et al. American Rheumatism Association 1987 revised for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324
18. Fuchs H.A., Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum. 37:1994;470-475
19. Prevoo M.L.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B.A., van Riel P.L.C.M. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum. 38:1995;44-48
20. Kucukdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: example from the adaptation reliability and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire (HAQ). Arthritis Care Res (in press)
21. Fries J.F., Spitz P., Kraines R.G., Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum. 23:1980;137-145
22. Scott D.G.I., Bacon P.A., Tribe C.R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 60:1981;288-297
23. Wiik A., Rasmussen N., Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. van Venrooij W.J., Maini R.N. Manual of biological markers of disease. 1993;A9:1-A9:14 Kluwer Academic Publishers, Doordrecht
24. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 26:1999;743-745
25. Wiik A.S. Clinical use of serological tests for antineutrophil cytoplasmic antibodies. What do the studies say? Rheum Dis Clin North Am. 27:2001;799-813
26. Schönermarck U., Lamprercht P., Csernok E., Gross W.L. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology. 40:2001;178-184
27. Mustila A., Korpela M., Mustonen J., Helin H., Huhtala H., Soppi E., et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis. A marker of severe disease with associated nephropathy. Arthritis Rheum. 40:1997;710-717
28. Cohen Tervaert J.W., Goldschmeding R., Elema J.D., Limburg P.C., van der Giessen M., Huitema M.G., et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum. 33:1990;1264-1272